DocGo Inc. (NASDAQ:DCGO) Given Average Rating of “Buy” by Analysts

Shares of DocGo Inc. (NASDAQ:DCGOGet Free Report) have received an average rating of “Buy” from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have covered the stock in the last year is $10.83.

DCGO has been the topic of several analyst reports. Stifel Nicolaus lowered their price target on DocGo from $11.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. BTIG Research lowered their price target on DocGo from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Canaccord Genuity Group lowered their price target on DocGo from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday, April 11th. Needham & Company LLC lowered their price target on DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 29th. Finally, Cantor Fitzgerald lowered their price target on DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a report on Thursday, February 29th.

View Our Latest Research Report on DCGO

DocGo Stock Performance

Shares of DCGO opened at $3.42 on Friday. The firm has a market cap of $356.26 million, a PE ratio of 48.86, a PEG ratio of 0.34 and a beta of 0.91. The firm’s 50 day moving average price is $3.73 and its 200 day moving average price is $4.65. DocGo has a twelve month low of $2.78 and a twelve month high of $10.82.

DocGo (NASDAQ:DCGOGet Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The company had revenue of $199.25 million for the quarter, compared to analyst estimates of $195.48 million. On average, sell-side analysts anticipate that DocGo will post 0.35 earnings per share for the current fiscal year.

Insider Transactions at DocGo

In related news, Director Michael J. Burdiek acquired 10,000 shares of the stock in a transaction dated Thursday, March 14th. The shares were acquired at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the completion of the purchase, the director now owns 571,595 shares in the company, valued at approximately $2,063,457.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 13.78% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On DocGo

Institutional investors have recently bought and sold shares of the business. Federated Hermes Inc. acquired a new stake in DocGo during the third quarter worth $29,000. Royal Bank of Canada boosted its stake in DocGo by 226.3% during the first quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after buying an additional 2,263 shares in the last quarter. AJOVista LLC bought a new position in shares of DocGo during the fourth quarter valued at $25,000. Tower Research Capital LLC TRC lifted its holdings in shares of DocGo by 145.6% during the third quarter. Tower Research Capital LLC TRC now owns 5,908 shares of the company’s stock valued at $31,000 after acquiring an additional 3,502 shares during the period. Finally, Wells Fargo & Company MN lifted its holdings in shares of DocGo by 320.1% during the fourth quarter. Wells Fargo & Company MN now owns 6,192 shares of the company’s stock valued at $44,000 after acquiring an additional 4,718 shares during the period. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

(Get Free Report

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.